Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01688388 · ClinicalTrials.gov registry record · NA
Single Fraction Intraoperative Radiotherapy
A NA study of Stage II Breast Carcinoma and Stage 0 Breast Carcinoma, sponsored by St. Joseph Hospital of Orange.
- Completed
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 1
- Study location
NCT01688388: Completed NA study of Stage II Breast Carcinoma and Stage 0 Breast Carcinoma, sponsored by St. Joseph Hospital of Orange.
NCT01688388 is a NA study of Stage II Breast Carcinoma and Stage 0 Breast Carcinoma that has completed, run by St. Joseph Hospital of Orange. The registered enrollment target is 250 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01688388, a NA study of Stage II Breast Carcinoma and Stage 0 Breast Carcinoma, has completed, sponsored by St. Joseph Hospital of Orange.
- COMPLETED
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial is being conducted to find out the effects (good and bad) of giving the full radiation treatment for breast cancer as a single dose of radiation during surgery for breast cancer. This single fraction intraoperative radiotherapy with electrons will study the toxicity, local control and cosmetic outcome.
Primary Outcome
Assessment of acute toxicity of breast irradiation according to CTC-toxicity Scoring - system: * End of initial surgical phase: Week 1, 4 * First Follow-up investigation: Month 2 Assessment of late toxicity according to NSABP scoring-systems at 6, 12, 24, 36, 48, and 60 months
Conditions Studied
Interventions
- PROCEDURE Intraoperative Radiotherapy
Study Locations (1)
California
- St. Joseph Hospital of Orange - Orange
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2012-02 |
| Est. Completion | 2022-02 |
| Phase | NA |
What the finished NCT01688388 record still lists
NCT01688388 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).
The record links to 4 conditions, with Stage II Breast Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which Intraoperative Radiotherapy is the first listed.
NCT01688388 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01688388 about?
NCT01688388 is a clinical study titled "Single Fraction Intraoperative Radiotherapy". This clinical trial is being conducted to find out the effects (good and bad) of giving the full radiation treatment for breast cancer as a single dose of radiation during surgery for breast cancer. This single fraction intraoperative radiotherapy with electrons will study the toxicity, local contro...
What is the current status of trial NCT01688388?
This trial is currently completed. It is a NA study. The enrollment target is 250 participants. The study started on 2012-02. Estimated completion is 2022-02.
What conditions does trial NCT01688388 study?
This clinical trial studies the following conditions: Stage II Breast Carcinoma, Stage 0 Breast Carcinoma, Stage I Breast Carcinoma, Invasive Ductal and Invasive Lobular Breast Carcinoma.
What interventions are being tested in trial NCT01688388?
The interventions under investigation include: Intraoperative Radiotherapy (PROCEDURE).
Who is sponsoring clinical trial NCT01688388?
This trial is sponsored by St. Joseph Hospital of Orange, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01688388 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stage II Breast Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01688388's enrollment target sits among peer trials
250 410th of 2000 higher than 1,567 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia